| General Information of Drug (ID:
DR2076) |
| Drug Name |
BRN-0087671
|
| Synonyms |
Carnosine; Ignotine; Karnozin; Karnozzn; L-Carnosine; L-Carnosine, 98%; L-HISTIDINE, N-beta-ALANYL-; L-Histidine, N-.beta.-alanyl-; L-Histidine, beta-alanyl-; L-Ignotine; N-beta-alanyl-L-histidine; Nalpha-(beta-alanyl)-L-histidine; beta-Alanyl-L-histidine; (2S)-2-(3-aminopropanamido)-3-(1H-imidazol-4-yl)propanoic acid; (2S)-2-(3-aminopropanoylamino)-3-imidazol-4-ylpropanoic acid; 305-84-0; 8HO6PVN24W; BRN 0087671; CHEBI:15727; CQOVPNPJLQNMDC-ZETCQYMHSA-N; EINECS 206-169-9; MFCD00005207; N-2-M; NSC 524045; UNII-8HO6PVN24W
|
| Indication |
Schizophrenia
[ICD11: 6A20]
|
Phase 2/3
|
[1]
|
| Structure |
|
 |
|
3D MOL
|
2D MOL
|
| Pharmaceutical Properties |
Molecular Weight |
226.23 |
Topological Polar Surface Area |
121 |
| Heavy Atom Count |
16 |
Rotatable Bond Count |
6 |
| Hydrogen Bond Donor Count |
4 |
Hydrogen Bond Acceptor Count |
5 |
| Cross-matching ID |
- PubChem CID
- 439224
- PubChem SID
-
3676
; 3138777
; 8143363
; 10298255
; 11113307
; 11341645
; 11361828
; 11364072
; 11366634
; 11369196
; 11372223
; 11375363
; 11377358
; 11484264
; 11487230
; 11488270
; 11491027
; 11493487
; 11494992
; 11537748
; 15121551
; 15121552
; 15196090
; 15220561
; 24893178
; 26612130
; 26679654
; 26754272
; 36883477
; 47574407
; 48095570
; 49747061
; 53837760
; 74607942
; 85165054
; 87561884
; 88835064
; 92715522
; 103529382
; 104619952
; 117531262
; 118260670
; 124558660
; 124636547
; 124883182
; 126522966
; 126608870
; 126622085
; 126623164
; 126653762
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0M9BA
- Formula
- C9H14N4O3
- Canonical SMILES
- C1=C(NC=N1)CC(C(=O)O)NC(=O)CCN
- InChI
- 1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1
- InChIKey
- CQOVPNPJLQNMDC-ZETCQYMHSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.